Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | salsolinol | 9687 | drug-path |
| Asthma | R-HSA-444620 | map05310 | salsolinol | 9687 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | salsolinol | 9687 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | salsolinol | 9687 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | salsolinol | 9687 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | salsolinol | 9687 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | salsolinol | 9687 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | salsolinol | 9687 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | salsolinol | 9687 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | oxybenzone | 2315 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | oxybenzone | 2315 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | oxybenzone | 2315 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | oxybenzone | 2315 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | oxybenzone | 2315 | drug-path |
| Non-homologous end-joining | R-HSA-5693571 | map03450 | oxybenzone | 2315 | drug-path |
| Asthma | R-HSA-444620 | map05310 | oxybenzone | 2315 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | oxybenzone | 2315 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | oxybenzone | 2315 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | oxybenzone | 2315 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | parbendazole | 9642 | drug-path |